TOKYO -- Japanese drugmaker Takeda Pharmaceutical is set to issue up to $20 billion (2.2 trillion yen) in bonds to finance its acquisition of Ireland-based drugmaker Shire, in what would be the biggest-ever debt issuance by a Japanese company, Nikkei learned Monday.
The plan would allow the Osaka-based company to take advantage of low interest rates in Japan, where many institutional investors are hungry for investment opportunities offering higher yields.
